FI49497C - Förfarande för framställning av terapeutiskt verksamma 1-fenoxi-2-hydr oxi-3-alkylaminopropaner. - Google Patents

Förfarande för framställning av terapeutiskt verksamma 1-fenoxi-2-hydr oxi-3-alkylaminopropaner.

Info

Publication number
FI49497C
FI49497C FI683535A FI353568A FI49497C FI 49497 C FI49497 C FI 49497C FI 683535 A FI683535 A FI 683535A FI 353568 A FI353568 A FI 353568A FI 49497 C FI49497 C FI 49497C
Authority
FI
Finland
Prior art keywords
alkylaminopropanes
phenoxy
preparation
therapeutically active
therapeutically
Prior art date
Application number
FI683535A
Other languages
English (en)
Finnish (fi)
Other versions
FI49497B (sv
Inventor
Herbert Koeppe
Werner Kummer
Helmut Staehle
Karl Zeile
Albrecht Engelhardt
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Application granted granted Critical
Publication of FI49497B publication Critical patent/FI49497B/fi
Publication of FI49497C publication Critical patent/FI49497C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI683535A 1967-12-13 1968-12-11 Förfarande för framställning av terapeutiskt verksamma 1-fenoxi-2-hydr oxi-3-alkylaminopropaner. FI49497C (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1643262A DE1643262C3 (de) 1967-12-13 1967-12-13 i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FI49497B FI49497B (sv) 1975-04-01
FI49497C true FI49497C (sv) 1975-07-10

Family

ID=5684274

Family Applications (1)

Application Number Title Priority Date Filing Date
FI683535A FI49497C (sv) 1967-12-13 1968-12-11 Förfarande för framställning av terapeutiskt verksamma 1-fenoxi-2-hydr oxi-3-alkylaminopropaner.

Country Status (21)

Country Link
US (1) US3872147A (sv)
JP (1) JPS5220457B1 (sv)
AT (13) AT292679B (sv)
BE (1) BE725490A (sv)
BG (9) BG17298A3 (sv)
BR (1) BR6804840D0 (sv)
CA (1) CA954528A (sv)
CH (2) CH556816A (sv)
DE (1) DE1643262C3 (sv)
DK (1) DK131029B (sv)
ES (11) ES361189A1 (sv)
FI (1) FI49497C (sv)
FR (2) FR1596100A (sv)
GB (1) GB1260866A (sv)
HU (1) HU162734B (sv)
IE (1) IE32758B1 (sv)
IL (1) IL31266A (sv)
NL (3) NL146709B (sv)
PH (1) PH9266A (sv)
SE (1) SE367396B (sv)
YU (12) YU33949B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541130A (en) * 1967-02-06 1970-11-17 Boehringer Sohn Ingelheim 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
US3998874A (en) * 1971-03-23 1976-12-21 Gist-Brocades N.V. Phenylene di-ethers
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
US4084002A (en) * 1973-02-28 1978-04-11 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
DE2309887C2 (de) * 1973-02-28 1983-11-10 C.H. Boehringer Sohn, 6507 Ingelheim 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen
US4161530A (en) * 1975-01-06 1979-07-17 Ciba-Geigy Corporation Pharmaceutical combination preparations as hypnotics
US4094991A (en) * 1975-06-17 1978-06-13 Nippon Shinyaku Co., Ltd. Substituted n-(carboxymethyl)-3-aminopropan-2-ol derivatives
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
DE2839475A1 (de) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik Isopropylamin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
JPS56142262A (en) 1980-04-08 1981-11-06 Nippon Shinyaku Co Ltd Piperazine derivative
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
DE3131527A1 (de) * 1981-08-08 1983-02-24 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH0720861B2 (ja) * 1984-04-09 1995-03-08 ザ デュポン マーク ファーマソウテイカル カンパニー 心臓障害の処置または予防用の医薬組成物および方法
US4652584A (en) * 1984-07-13 1987-03-24 Mcneilab, Inc. Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure
ES2011255B3 (es) * 1985-12-24 1990-01-01 Merck & Co Inc Bloqueadores beta selectivos para los ojos.
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
US5480908A (en) * 1993-12-13 1996-01-02 American Cyanamid Company β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes

Also Published As

Publication number Publication date
YU237874A (en) 1977-12-31
GB1260866A (en) 1972-01-19
BG16329A3 (bg) 1972-08-20
CH556816A (de) 1974-12-13
ES375453A1 (es) 1972-05-16
YU237774A (en) 1978-02-28
NL6817768A (sv) 1969-06-17
YU237674A (en) 1977-10-31
ES375444A1 (es) 1972-05-01
DE1643262B2 (de) 1974-11-07
ES375448A1 (es) 1972-05-01
ES375449A1 (es) 1972-05-01
YU238374A (en) 1977-12-31
IE32758B1 (en) 1973-11-28
BG16444A3 (bg) 1972-11-20
YU294968A (en) 1978-02-28
YU237574A (en) 1978-02-28
AT292674B (de) 1971-09-10
SE367396B (sv) 1974-05-27
HU162734B (sv) 1973-04-28
YU33855B (en) 1978-06-30
AT292679B (de) 1971-09-10
AT292678B (de) 1971-09-10
DK131029C (sv) 1975-10-06
YU33852B (en) 1978-06-30
NL7501794A (nl) 1975-05-30
DK131029B (da) 1975-05-20
FR1596100A (sv) 1970-06-15
YU33773B (en) 1978-05-15
AT292680B (de) 1971-09-10
IL31266A (en) 1974-09-10
AT292673B (de) 1971-09-10
AT292675B (de) 1971-09-10
CH532015A (de) 1972-12-31
ES361189A1 (es) 1970-08-16
ES375451A1 (es) 1972-05-01
ES375445A1 (es) 1972-05-16
BG19135A3 (sv) 1975-04-30
DE1643262C3 (de) 1975-06-26
YU33853B (en) 1978-06-30
FR8328M (sv) 1970-12-07
BG16332A3 (bg) 1972-08-20
PH9266A (en) 1975-07-30
BG16445A3 (bg) 1972-11-20
FI49497B (sv) 1975-04-01
CA954528A (en) 1974-09-10
YU238174A (en) 1977-10-31
AT298459B (de) 1972-05-10
YU33946B (en) 1978-09-08
AT292677B (de) 1971-09-10
AT298463B (de) 1972-05-10
YU238474A (en) 1978-02-28
ES375446A1 (es) 1972-05-01
NL151354B (nl) 1976-11-15
ES375447A1 (es) 1972-05-01
YU237474A (en) 1977-12-31
YU33947B (en) 1978-09-08
BG16331A3 (bg) 1972-08-20
AT292670B (de) 1971-09-10
YU237974A (en) 1977-12-31
YU33774B (en) 1978-05-15
NL7501792A (nl) 1975-05-30
DE1643262A1 (de) 1972-04-20
US3872147A (en) 1975-03-18
BR6804840D0 (pt) 1973-03-08
YU33854B (en) 1978-06-30
YU33851B (en) 1978-06-30
AT292676B (de) 1971-09-10
NL146709B (nl) 1975-08-15
BE725490A (sv) 1969-06-13
BG16330A3 (bg) 1972-08-20
ES375450A1 (es) 1972-05-01
YU33856B (en) 1978-06-30
BG17298A3 (sv) 1973-07-25
YU33948B (en) 1978-09-08
AT292681B (de) 1971-08-15
YU238274A (en) 1977-12-31
IL31266A0 (en) 1969-02-27
ES375452A1 (es) 1972-05-16
AT294799B (de) 1971-12-10
JPS5220457B1 (sv) 1977-06-03
BG17297A3 (sv) 1973-07-25
YU33949B (en) 1978-09-08
IE32758L (en) 1969-06-13
YU238074A (en) 1977-12-31

Similar Documents

Publication Publication Date Title
DK128318B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bischromoner.
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
FI49957C (sv) Förfarande för framställning av terapeutiskt verksamma oximetrar.
FI49497C (sv) Förfarande för framställning av terapeutiskt verksamma 1-fenoxi-2-hydr oxi-3-alkylaminopropaner.
FI48727C (sv) Förfarande vid framställning av acetylguanidiner.
FI50707C (sv) Förfarande för framställning av nya farmakologiskt aktiva hydroxicyklo hexylaminer.
FI49720C (sv) Förfarande för framställning av terapeutiskt verksamma 2-metyl-3-karbo nsyraamidokinoxalin-di-N-oxider-(1,4).
FI52857C (sv) Förfarande för framställning av terapeutiskt verksamma amidoximer.
FI45551C (sv) Förfarande för framställning av terapeutiskt användbart dehydroepiandr osteronönantat.
DK117635B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler.
FI49718C (sv) Förfarande för framställning av terapeutiskt verksamma 2-halogenmetyl- 3-karbonsyraamidokinoxalin-di-N-oxider-(1,4)
FI51175C (sv) Förfarande för framställning av terapeutiskt användbara indanyltiokarb amater.
FI49032C (sv) Förfarande för framställning av terapeutiskt aktiva 7-nitro-8-hydroxi- kinolin-estrar.
FI50420C (sv) Förfarande för framställning av terapeutiskt aktiva 4-pyrimidinyl-1,4- dihydropyridinderivat
FI47189C (sv) Förfarande för framställning av terapeutiskt aktiva d-lyserginsyra-N-f enylpiperazider.
FI48576C (sv) Förfaringssätt för framställning av terapeutiskt aktiva alfa-fluor-mal onsyraderivat.
FI46066C (sv) Analogiförfarande för framställning av terapeutiskt verksamma N,N-dime tylaminoetyl-14beta-hydroxi-5beta-pregn-20-en-21-karboxylat.
FI48190C (sv) Förfarande för framställning av terapeutiskt aktiva 10alfa-metoxi-9,10 -dihydroergolinderivat
FI50879C (sv) Förfarande för framställning av terapeutiskt verksamma sybstituerade 3 -aminoacylamino-tiofener.
FI48841C (sv) Analogiförfarande för framställning av farmakologiskt aktiva 5-nitro-2 -furfurylidenaminooxazolidinoner.
FI45553C (sv) Förfarande för framställning av terapeutiskt användbara 16-tiosubstitu erade 9beta,10alfa-pregnener
FI47661C (sv) Förfarande för framställning av terapeutiskt verkande bensofuranderiva t.
FI47651C (sv) Sätt att framställa dikvävetetroxid.
FI49722C (sv) Förfarande för framställning av terapeutiskt verksamma 3-karbonsyraami do-kinoxalin-di-N-oxider-(1,4).
DK122763B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 1,2α-methylen-4-pregnen-3,20-dionderivater.